Analysts: Ebos paid nearly twice as much as usual for HPS
Ebos' expensive HPS purchase was a defensive move
Ebos is paying nearly twice as much for hospital pharmacy company HPS than it usually pays for the businesses it buys, analysts say.
It paid $A154 million for HPS and said it would increase 2018 operating earnings by at least 5%.
The consensus among analysts before the purchase was that Ebos’
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Jenny Ruth
Mon, 29 May 2017
Mon, 29 May 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Analysts: Ebos paid nearly twice as much as usual for HPS
67333